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Abstract. The present work demonstrates the possibility of production of personalized implants from bioresorbable 
polymers designed for replacement of bone defects. The stages of creating a personalized implant are described, which 
include the obtaining of 3D model from a computer tomogram, development of the model with respect to shape of bone 
fitment bore using Autodesk Meshmixer software, and 3D printing process from bioresorbable polymers. The results of 
bioresorbable polymer scaffolds implantation in pre-clinical tests on laboratory animals are shown. The biological 
properties of new bioresorbable polymers based on poly(lactic acid) were studied during their subcutaneous, 
intramuscular, bone and intraosseous implantation in laboratory animals. In all cases, there was a lack of a fibrous 
capsule formation around the bioresorbable polymer over time. Also, during the performed study, conclusions were made 
on osteogenesis intensity depending on the initial state of bone tissue.
INTRODUCTION
At the present stage of the development of the reconstructive and plastic surgery, the need for development and 
introduction of synthetic (composite) tissue-substitutive materials designed to reduce surgical trauma and 
complications while maintaining high efficiency is becoming increasingly evident [1, 2]. Biodegradable polymers 
such as poly(ODFWLFDFLGDQGSRO\İ-caprolactone) became widely used in production of biomedical devices due do 
their biocompatibility and ability to resorb [3]. To increase the ability of such materials to substitute bone tissue, a 
number of modification methods were developed [4, 5].
There are a number of requirements to implants for bone defects replacement. The implant must fit the shape, 
volume, structure and consistency of the tissue and function of the organ that is restored. Mismatch of the geometry 
of osteoimplant and geometry of the resected fragment of facial skeleton entails limited mechanical functionality, a 
violation of facial mimics and articulation [6]. Simultaneous replacement of the defect requires the development of 
original medical personalized product that includes stages of diagnosis, visualization of the alleged defect based on 
use of computed tomography, computer simulation of the planned implant, manufacture of the model, supporting 
framework of the implant, modification of surface properties of the implant in accordance with individual 
characteristics of each clinical case. Such approach can be realized only with the use of 3D technologies, which are a 
world trend in creation of biocompatible materials for osteosubstitution.
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FIGURE 1. Stages of 3D implant fabrication
MATERIALS AND METHODS
Technology of Biodegradable 3D Implants Fabrication
The technology of bone structure modeling is based on complex processing of the obtained medical images and 
includes a number of stages. First of all, computer tomography is being conducted. Multispiral scanning in soft or 
bone tissue regime with slices thickness of not greater than 0.5 mm is taken as standard. The obtained models have 
DICOM format and are used at the next stage, virtual modeling. For that purpose, additional software is used to 
convert DICOM files into .stl files. In our case 3Dslicer software was used for multistep modeling: 1) cropping the 
“area of interest” of 3D-printing; 2) artefacts cutting; 3) selection of the densities range (not less than 
150 Hounsfield units for bone tissue); 4) the smoothing and reduction of background noise. The listed manipulations 
result in the virtual model of the “area of interest” in .stl format. Then, the obtained model may be used for 3D 
printing or for production of the personalized implant with bone fitment bore. After 3D modeling, 3D model is being 
prepared for printing. Stl file is being loaded to slicer program that is used for preparation of the model for printing. 
3D printing of the implant is conducted after all preparation steps. The stages of implant fabrication are presented in 
Fig. 1.
Investigation of Osteointegrative Properties of Poly(Lactic Acid)-Based Implants
To investigate the ability of bioresorbable poly(lactic acid)-based implants to integrate into bone tissue we 
used non-woven implants produced by previously reported method [7]. In vitro studies of bioresorbable poly(lactic 
acid)-based materials were presented earlier [8]. The osteointegrative properties of non-woven implants were tested
on 48 male Wistar rats with mass of 180–200 g grown in E.D. Goldberg Scientific and research institute of 
pharmacology and regenerative medicine. The experiments were carried out according to the principles set out in 
EU prescriptions (86/609/ȿȿɋDQG+HOVLQNLGHFODUDWLRQ
Three groups consisting of 16 animals were formed:
1. Animals with implanted biodegradable implant made of PURASORB PL-38 poly(lactic acid);
2. Animals with implanted composite implant made of PURASORB PL-38 poly(lactic acid) and mineral filler 
made of dihydrous dicalcium phosphate and produced by laser ablation method;
3. Animals with implanted composite implant made of PURASORB PL-38 poly(lactic acid) and mineral filler 
made of hydroxyapatite and produced by laser ablation method.
Implantation of Non-Woven Materials
Material implantation was performed under general mixed intramuscular anesthesia (anesthetics dose was 
calculated according to the animal’s mass from the following proportions: 5–7 mg/kg of Zoletil and 4 mg/kg of 
Rometar). After the analysis of the anatomical and physiological features of the rats, two areas were selected for 
extramedullary implantation: calvarial (or parietal) and pelvic (or upper hip) bones.
Cranial bones access was achieved on midline via skin dissection and lateral traction of temporal muscles with 
parietal bone cortex using raspatory. Access to upper hip bones was obtained from the right and left sides in 
longitudinal direction. The length of skin incision was from 12 to 20 mm. Two sterile samples with size of 7–9 mm 
were implanted to parietal bones projection. Two similar samples were implanted into upper hip bones projection 
(Fig. 2). 
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FIGURE 2. Sample implantation on: (a) calvarial and (b) upper hip bones of rats
Before the implantation, subperiostal access to parietal and inner surface of upper hip bones was achieved with 
scarification of the cortical plate with raspatory. The implant was placed on scarified bone surface and fixed with 
muscle tissue.
After the samples implantation, the implantation cites were stitched with 4.0 suture and treated with septicide. 
Physical activity of the rats recovered in 15–19 min after awakening. The follow-up period was from 15 to 90 days. 
In case of purulence or sutures eruption, the animal was excluded from the experiment. The rats were weighted each 
7 days.
Material Withdrawal
Four animals from each group were sacrificed after 15, 30, 60 and 90 days of experiment by narcosis (with 
Zoletil toxic doze of 35–40 mg/kg). Then, the tissue samples were prepared for morphological studies. For that 
purpose, calvarial and upper hip bones with implanted samples and covering muscle tissue were resected.
The tissue samples were fixed in 10% formalin for not less than 1 day. The bone tissue samples were decalcified 
in mixture of formic acid and 10% formalin with proportion of 1:4. Decalcification time was from several hours to 
5–7 days. After that, the tissue was dehydrated and soaked in paraffin using Leica Ⱥ63-300S tissue processor. The 
sample was fixed in hystological cassetes. The slices 5–7 Pm thick were prepared using Leica RM 2255 microtome, 
placed on object plates and stained with hematoxylin and eosin in Thermo Gemini AS stainer. Microscopy studies 
were carried out using “Zeiss Axio Scope” optical microscope at ×100 and ×200 magnifications.
Examination of 3D Implant Ability to Substitute the Bone Defects
The aim of following experiment was in one-step substitution of long bone circumferential defect with formation 
of bone inside, as well as on the surface of the implant.
To provide penetration of blood capillaries from the surrounding soft tissues and regeneration of intraosseous 
blood flow, the implant was fabricated as highly porous cylinder with the following dimensions: 40 mm high,
14 mm in diameter, 2 mm of wall thickness, depth of bone fitment bore of 10 mm.
The implant is presented as a porous cylinder with 300–500 Pm open-ended inner pores crossing 1.0–1.5 mm 
cells. Such construction of the implant restores bone blood supply in periost, intramedullary blood flow and bone 
marrow, resulting in strong implant osteointegration.
Shin bone defect was simulated by resection of part of the diaphysis of dog shin bone 20 mm high, 15–18% of 
the bone length.
Taking into account the low strength of bioresorbable implant, primal osteosynthesis was carried out by Ilizarov 
frame for fixation of the implant. Then, tibial crest was exposed to longitudinal section with length of 40–50 mm 
and diaphysis was accessed by replacement of muscles and cortex. 20 mm section of the diaphysis was subperiosteal 
resected with vibrating saw. The implant was placed on adjacent ends of bones and cortex, soft tissues and skin were 
sutured.
RESULTS AND DISCUSSION
Osteointegration Properties of Bioresorbable Materials
Good implant fixation to surrounding muscle tissues (starting from 15 days of experiment) and cortex (starting 
from 60 days) was observed in all groups due to connective tissue invasion. The connective tissue membrane was 
transient and smooth.
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FIGURE 3. Withdrawal of Group 2 implant sample after 15 days: (a) upper hip and (b) calvarial bone
In 30 days of experiment, microvascular web was formed around the implant. Up to 15 days the implant was 
visualisable in surrounding muscle tissues as a white object (Fig. 3).
Thus, microscopic differences among the studied groups of implants withdrawn in different times were not found. 
Good integration of the implants into surrounding tissues, increasing biodegradation (from 15 to 90 days) and 
absence of visual signs of inflammation were noted.
Microscopy characterization of the implantation cites in different observation time (15, 30, 60 and 90 days) was 
conducted. The most interesting results were obtained in 90 days of experiment. In the first group, 70–90% 
resorption of the material was observed with the tendency to reduction of the number of giant cells and increase in 
fibroblasts. Slight osteogenesis in the areas contacting with bone was found (Fig. 4).
In the same period, in the second group irregular material resorption (50–100%) was observed. Remained giant 
cells-containing infiltrate demonstrated reduction in the number of giant cells and increase of fibroblasts. Significant 
osteogenesis was observed in all cases (Fig. 5).
(a) (b)
FIGURE 4. Group 1 after 90 days of implantation: 1—bone tissue with signs of scarification, 2—remained part 
of the implant, 3—inflammatory infiltrate with multinucleate giant cells, 4—formed bone rods. 
(a) ×100 magnification; (b) ×200 magnification
(a) (b)
FIGURE 5. Group 2 after 90 days of implantation: 1—bone tissue with signs of scarification, 2—remained part 
of the implant, 3—inflammatory infiltrate containing giant cells, 4—formed bone rods. (a) ×100 magnification, 
(b) ×200 magnification
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FIGURE 6. Group 3 after 90 days of implantation: 1—bone tissue with signs of scarification, 2—remained part 
of the implant, 3—inflammatory infiltrate containing giant cells, 4—formed bone rods. (a) ×100 magnification, 
(b) ×200 magnification
At the end of experiment (90 days) irregular resorption (50–100%) of the material was observed in the third 
group. Remained giant cells-containing infiltrate demonstrated reduction of the number of giant cells and increase of 
fibroblasts. Significant osteogenesis was found only in 25% of cases, while in 75% it was slight and observed in 
areas contacted with bone (Fig. 6).
The conducted studies demonstrated that biodegradable implant made of PURASORB PL-38 poly(lactic acid) 
and hydrous dicalcium phosphate produced by laser ablation as filler induced more intensive osteogenesis.
Substitution of Bone Defects by Bioresorbable 3D Implants
The experiments on substitution of long bone circumferential defect (up to 18% of bone length) demonstrated 
that osteointegration of bioresorbable implant is equivalently intensive both from proximal and distal fragments 
(Fig. 7). A bone defect with a length of 20 mm was viewable in a post-operational X-ray image. The implant was 
transparent and produced no X-ray boundary (Fig. 7a).
X-ray boundary of bone graft appears after 14 days from the operation as a periosteal reaction around the implant 
shell (Fig. 7b). From the X-ray images it is obvious that bone graft X-ray boundary grows more intensively from 
proximal fragment (Fig. 7c). After two months of fixation, diastasis was nearly filled with bone graft and thin layer 
between proximal and distal fragments (Fig. 7d).
(a) (b) (c) (d) (e)
FIGURE 7. Radiographs of the lower leg of the experimental animal on the day of surgery (a); in the process 
of osteointegration of the bioresorbable implant after fixation (operation): (b) 14 days; (c) 35 days; 
(d) 2 months; (e) 4 months (in a straight line and lateral projections)
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After 4 months of fixation (Fig. 7e), all parts of bone graft are connected into bone-implant complex, showing 
completed osteointegration.
During the post-operational period, high porosity of the implant supports circulation of biological fluids and 
allows them to penetrate into the implant. Also, it provides the ability of blood capillaries to grow into the implant.
CONCLUSION
The present article describes a promising method of implant fabrication combining computer tomogram 
technology and 3D-printing. The full process of personalized bone implant production is demonstrated. Moreover, 
the studies of novel composite materials made of bioresorbable polymer and various calcium phosphates in animal 
model show their effectiveness for formation of new bone tissue. Thus, the obtained data will be used for fabrication 
of personalized implants for bone defects substitution.
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